(Q37438938)

English

Heparin cofactor II in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study

scientific article published on 09 September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Heparin cofactor II in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jill C Rau

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Carolyn Deans

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Maureane R Hoffman

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

David B Thomas

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Gray T Malcom

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Arthur W Zieske

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Jack P Strong

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Gary G Koch

8

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Frank C Church

9

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

9 September 2009

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Experimental and Molecular Pathology

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

87

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

178-183

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

23 August 2017

Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

23 August 2017

Serpins in thrombosis, hemostasis and fibrinolysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

23 August 2017

Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

23 August 2017

Heparin cofactor II modulates the response to vascular injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

23 August 2017

Implications of early structural-functional changes in the endothelium for vascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

23 August 2017

The roles of proteinase-activated receptors in the vascular physiology and pathophysiology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

23 August 2017

Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

23 August 2017

C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

23 August 2017

High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stenting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

23 August 2017

Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall: A potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

23 August 2017

Role of the thrombin receptor in restenosis and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

23 August 2017

Decreased heparin cofactor II activity is associated with impaired endothelial function determined by brachial ultrasonography and predicts cardiovascular events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

14 September 2017

Thrombin hypothesis of thrombus generation and vascular lesion formation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

14 September 2017

New insights into the pathogenesis of atherosclerosis as revealed by PDAY. Pathobiological Determinants of Atherosclerosis in Youth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

14 September 2017

A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

28 September 2017

The PDAY Study: natural history, risk factors, and pathobiology. Pathobiological Determinants of Atherosclerosis in Youth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

26 June 2018

Increased apolipoprotein deposits in early atherosclerotic lesions distinguish symptomatic from asymptomatic patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

2 September 2018

The potential role of resistin in atherogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

2 September 2018

Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

2 September 2018

High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

2 September 2018

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2783423

2 October 2018

Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.003

7 January 2021

Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.003

7 January 2021

Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor II

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.003

7 January 2021

Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.003

7 January 2021

Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.003

7 January 2021

Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.09.003

7 January 2021

The clinical morphology of human atherosclerotic lesions. Lessons from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth

1 reference

https://pubmed.ncbi.nlm.nih.gov/19747479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/19747479

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.YEXMP.2009.09.003

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37438938&oldid=2121746872"